Radiologic Characteristics of Surgically Resected Non-Small Cell Lung Cancer With ALK Rearrangement or EGFR Mutations

被引:52
|
作者
Kim, Tae Jung
Lee, Choon-Taek
Jheon, Sang Hoon
Park, Jeong-Soo
Chung, Jin-Haeng [1 ]
机构
[1] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam 463707, Gyeonggi Do, South Korea
来源
ANNALS OF THORACIC SURGERY | 2016年 / 101卷 / 02期
关键词
EML4-ALK FUSION GENE; FACTOR RECEPTOR MUTATION; CT CHARACTERISTICS; ADENOCARCINOMA; CLASSIFICATION; FEATURES; GEFITINIB; SURVIVAL;
D O I
10.1016/j.athoracsur.2015.07.062
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Radiogenomic features are predictive of anaplastic lymphoma kinase (ALK) rearrangement in surgically resected non-small cell lung cancer (NSCLC). Methods. ALK rearrangement was screened by fluorescent in situ hybridization in 497 patients with resected NSCLC. Of these, 198 patients screened for both ALK and epidermal growth factor receptor (EGFR) mutation were enrolled. Clinicopathologic findings, survival after surgical procedure, computed tomographic (CT) features, and maximum standardized uptake value according to different genotypes were investigated with univariate and multivariate analyses. A receiver operating characteristic (ROC) curve analysis was performed to quantify the predictive value of these factors. Results. The prevalence of ALK positivity in resected NSCLC was 5.0% (25 of 497). Patients with ALK rearrangement showed significant differences in terms of patient's age (p = 0.006 for ALK versus EGFR, and 0.04 for ALK versus wild type [WT]/WT, respectively), solid lesion (p = 0.0074 for ALK versus EGFR), degree of contrast enhancement (p = 0.0006 for ALK versus EGFR), and lesion margin (p = 0.0011 for ALK versus EGFR, and 0.0314 for ALK versus WT/WT, respectively) compared with EGFR mutant and WT/WT cohorts. Multivariate analysis revealed that young age, solid lesion, lobulated margin, and hypoattenuation at contrast-enhanced CT scan were independent predictors of ALK positivity (p = 0.027, 0.046, 0.001, 0.021, respectively). The area under the ROC curve of the predictive model was 0.832, which suggests good discrimination. Conclusions. ALK-rearranged lung cancer has characteristic clinical and imaging features compared with EGFR mutant or WT/WT cohorts. Our findings suggest that young age, lobulated margin, solid lesion, and hypoattenuation at contrast-enhanced CT scan are important predictors of ALK-rearranged lung cancer. (C) 2016 by The Society of Thoracic Surgeons
引用
收藏
页码:473 / 480
页数:8
相关论文
共 50 条
  • [1] Adjuvant Treatments for Surgically Resected Non-Small Cell Lung Cancer Harboring EGFR Mutations A Review
    Passaro, Antonio
    Mok, Tony S. K.
    Attili, Ilaria
    Wu, Yi-Long
    Tsuboi, Masahiro
    de Marinis, Filippo
    Peters, Solange
    [J]. JAMA ONCOLOGY, 2023, 9 (08) : 1124 - 1131
  • [2] Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer
    Hu, Haoyue
    Tan, Songtao
    Xie, Meng
    Guo, Peng
    Yu, Qiang
    Xiao, Juan
    Zhao, Kangrui
    Liao, Qiong
    Wang, Yi
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [3] ALK Rearrangement and EGFR Copy Number Gains/mutations in Czech Non-small Cell Lung Cancer Patients
    Koudelakova, V.
    Trojanec, R.
    Kneblova, M.
    Drabek, J.
    Kolar, Z.
    Kolek, V.
    Mlcochova, S.
    Hajduch, M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : S139 - S139
  • [4] Clinical and computed tomography characteristics of non-small cell lung cancer with ALK gene rearrangement: Comparison with EGFR mutation and ALK/EGFR-negative lung cancer
    Mori, Mio
    Hayashi, Hideyuki
    Fukuda, Minoru
    Honda, Sumihisa
    Kitazaki, Takeshi
    Shigematsu, Kazuto
    Matsuyama, Naohiro
    Otsubo, Mayumi
    Nagayasu, Takeshi
    Hashisako, Mikiko
    Tabata, Kazuhiro
    Uetani, Masataka
    Ashizawa, Kazuto
    [J]. THORACIC CANCER, 2019, 10 (04) : 872 - 879
  • [5] EGFR inhibitors as adjuvant therapy for resected non-small cell lung cancer harboring EGFR mutations
    Tang, Wenjie
    Li, Xiaolin
    Xi, Xueqi
    Sun, Xindong
    Liu, Jie
    Zhang, Jian
    Wang, Chungang
    Yu, Jinming
    Xie, Peng
    [J]. LUNG CANCER, 2019, 136 : 6 - 14
  • [6] Adjuvant chemotherapy for surgically resected non-small cell lung cancer
    Heon, Stephanie
    Johnson, Bruce E.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2012, 144 (03): : S39 - S42
  • [7] Beyond EGFR and ALK: targeting rare mutations in advanced non-small cell lung cancer
    Gkolfinopoulos, Stavros
    Mountzios, Giannis
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (08)
  • [8] Cytological samples for the study of EGFR, KRAS and ALK mutations in non-small cell lung cancer
    Becker, Caroline
    Carcereny Costa, Enric
    Andreo Garcia, Felipe
    Castella, Eva
    Lletjos Sanuy, Mariona
    Moran, Teresa
    Mijangos Basterra, Erika
    Sanz Santos, Jose
    Centeno Clemente, Carmen
    Ruiz Manzano, Juan
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [9] Lack of prognostic value of EGFR mutations in primary resected non-small cell lung cancer
    Lim, Ken-Hong
    Huang, Ming-Jer
    Liu, Hung-Chang
    Kuo, Hsu-Tah
    Tzen, Chin-Yuan
    Hsieh, Ruey-Kuen
    [J]. MEDICAL ONCOLOGY, 2007, 24 (04) : 388 - 393
  • [10] Lack of prognostic value of EGFR mutations in primary resected non-small cell lung cancer
    Ken-Hong Lim
    Ming-Jer Huang
    Hung-Chang Liu
    Hsu-Tah Kuo
    Chin-Yuan Tzen
    Ruey-Kuen Hsieh
    [J]. Medical Oncology, 2007, 24 : 388 - 393